Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Ductal Carcinoma in Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00569166
What this trial is testing

Three Different Programs of Paced Breathing in Treating Hot Flashes in Women

Who this might be right for
Breast CancerFatigueHot Flashes+1 more
Mayo Clinic 105
Not applicableStudy completedNCT01052740
What this trial is testing

X-Ray Mammography Standard of Care Protocol

Who this might be right for
Breast CancerInvasive CarcinomaIn Situ Carcinoma+2 more
National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)Active Not RecruitingNCT05340673
What this trial is testing

Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast Carcinoma
City of Hope Medical Center 208
Not applicableLooking for participantsNCT06984250
What this trial is testing

Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer

Who this might be right for
Early Breast CancerDuctal Breast Carcinoma In Situ
National Taiwan University Hospital 315
Large-scale testing (Phase 3)Study completedNCT00438659
What this trial is testing

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast CancerDermatologic ComplicationsRadiation Toxicity+1 more
North Central Cancer Treatment Group 176
Large-scale testing (Phase 3)WithdrawnNCT00324714
What this trial is testing

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

Who this might be right for
Breast CancerOsteoporosis
ETOP IBCSG Partners Foundation
Not applicableLooking for participantsNCT03448926
What this trial is testing

The PREDICT Registry:

Who this might be right for
DCISStage 0 Breast CancerDuctal Breast Carcinoma In Situ
PreludeDx 3,000
Testing effectiveness (Phase 2)Ended earlyNCT01372618
What this trial is testing

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor

Who this might be right for
Ductal Carcinoma in Situ
NYU Langone Health 9
Not applicableStudy completedNCT00886535
What this trial is testing

Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Milton S. Hershey Medical Center 41
Testing effectiveness (Phase 2)Study completedNCT02314156
What this trial is testing

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Who this might be right for
BRCA1 Mutation CarrierBRCA2 Mutation CarrierDuctal Breast Carcinoma In Situ+6 more
Northwestern University 67
Not applicableStudy completedNCT00890994
What this trial is testing

Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)

Who this might be right for
Breast Cancer
Mayo Clinic 200
Not applicableStudy completedNCT04365114
What this trial is testing

Patient Outcomes from Second Film-readers and Test Threshold Relaxation in Breast Screening

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
University of Warwick 13,094,122
Not applicableStudy completedNCT02216136
What this trial is testing

Tumor: Breast Ratio Study

Who this might be right for
Breast CancerLCISDCIS
Washington University School of Medicine 162
Early research (Phase 1)Ended earlyNCT02876640
What this trial is testing

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+6 more
National Cancer Institute (NCI) 27
Not applicableNot Yet RecruitingNCT07527468
What this trial is testing

HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery

Who this might be right for
Breast CancerDuctal Carcinoma In SituInvasive Lobular Carcinoma+1 more
Hôpital du Valais 228
Not applicableLooking for participantsNCT06505577
What this trial is testing

Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study

Who this might be right for
MastectomyBreast Neoplasm Malignant Primary
Incheon St.Mary's Hospital 600
Early research (Phase 1)Study completedNCT01009437
What this trial is testing

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 28
Testing effectiveness (Phase 2)Ended earlyNCT00002934
What this trial is testing

Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ

Who this might be right for
Breast Cancer
Eastern Cooperative Oncology Group 711
Testing effectiveness (Phase 2)Looking for participantsNCT04084730
What this trial is testing

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Carcinoma, BreastDCIS+3 more
Memorial Sloan Kettering Cancer Center 280
Early research (Phase 1)Ended earlyNCT04185311
What this trial is testing

Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+19 more
Jonsson Comprehensive Cancer Center 6
Next Page